Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comparative Study
. 2013 Apr;61(4):886-93.
doi: 10.1161/HYPERTENSIONAHA.111.00662. Epub 2013 Feb 11.

Abnormal aldosterone physiology and cardiometabolic risk factors

Affiliations
Comparative Study

Abnormal aldosterone physiology and cardiometabolic risk factors

Anand Vaidya et al. Hypertension. 2013 Apr.

Abstract

Abnormal aldosterone physiology has been implicated in the pathogenesis of cardiometabolic diseases. Single aldosterone measurements capture only a limited range of aldosterone physiology. New methods of characterizing aldosterone physiology may provide a more comprehensive understanding of its relationship with cardiometabolic disease. We evaluated whether novel indices of aldosterone responses to dietary sodium modulation, the sodium-modulated aldosterone suppression-stimulation index (SASSI for serum and SAUSSI for urine), could predict cardiometabolic risk factors. We performed cross-sectional analyses on 539 subjects studied on liberal and restricted sodium diets with serum and urinary aldosterone measurements. SASSI and SAUSSI were calculated as the ratio of aldosterone on liberal (maximally suppressed aldosterone) to the aldosterone on restricted (stimulated aldosterone) diets and associated with risk factors using adjusted regression models. Cardiometabolic risk factors associated with either impaired suppression of aldosterone on liberal diet, or impaired stimulation on restricted diet, or both; in all of these individual cases, these risk factors associated with higher SASSI or SAUSSI. In the context of abnormalities that constitute the metabolic syndrome, there was a strong positive association between the number of metabolic syndrome components (0-4) and both SASSI and SAUSSI (P<0.0001) that was independent of known aldosterone secretagogues (angiotensin II, corticotropin, potassium). SASSI and SAUSSI exhibited a high sensitivity in detecting normal individuals with zero metabolic syndrome components (86% for SASSI and 83% for SAUSSI). Assessing the physiological range of aldosterone responses may provide greater insights into adrenal pathophysiology. Dysregulated aldosterone physiology may contribute to, or result from, early cardiometabolic abnormalities.

PubMed Disclaimer

Conflict of interest statement

CONFLICTS OF INTEREST/DISCLOSURES: none

Figures

Figure 1
Figure 1. The association of between the number of successive components of the MetS and aldosterone measures
Serum aldosterone concentrations are on LIB diet (A) and RES diet (B) are paralleled with urinary aldosterone excretion rates on LIB diet (D) and RES diet (E). Serum measures are expressed as the SASSI with respect to MetS components (C) and urine measures are expressed as the SAUSSI (F). Data are presented as box plots where boxes represent the 25th-75th percentiles and black horizontal dashes represent the median value.

References

    1. Briet M, Schiffrin EL. The role of aldosterone in the metabolic syndrome. Curr Hypertens Rep. 13:163–172. - PubMed
    1. Krug AW, Ehrhart-Bornstein M. Aldosterone and metabolic syndrome: Is increased aldosterone in metabolic syndrome patients an additional risk factor? Hypertension. 2008;51:1252–1258. - PubMed
    1. Tirosh A, Garg R, Adler GK. Mineralocorticoid receptor antagonists and the metabolic syndrome. Curr Hypertens Rep. 12:252–257. - PMC - PubMed
    1. Whaley-Connell A, Johnson MS, Sowers JR. Aldosterone: Role in the cardiometabolic syndrome and resistant hypertension. Prog Cardiovasc Dis. 52:401–409. - PMC - PubMed
    1. Tomaschitz A, Pilz S, Ritz E, Grammer T, Drechsler C, Boehm BO, März W. Association of plasma aldosterone with cardiovascular mortality in patients with low estimated gfr: The ludwigshafen risk and cardiovascular health (luric) study. Am J Kidney Dis. 2011;57:403–414. - PubMed

Publication types